20 ms·
In reality there's a spectrum. If the patent office would actually enforce the non-obvious clause rather than running as a cash cow then a lot of problems woul
by dasil003 17y ago
In reality there's a spectrum. If the patent office would actually enforce the non-obvious clause rather than running as a cash cow then a lot of problems would be solved off the bat.
I think of drug companies and software companies as the two extreme examples. Drug development is basically a money-losing proposition without patents, because it takes millions to get to anything useful, and once you do it's distilled down into something that's almost trivially easy to copy.
With software on the other hand, innovation happens in tiny steps. Often patents are granted to ideas that took someone a few days to come up with. As software is built, hundreds or thousands of these ideas come together to (hopefully) create a high value application. Once you have a high value application as long as you don't release the source code it's not easy to copy. The patents don't help someone recreate it. They have to pour blood and sweat into the codebase to come up with something that actually replicates the value. In other words the patent helps no one but the trolls.
Of course this is obvious to any software developer which is why we reflexively assume patents are bad. However in between software and drugs, in the space real physical inventions, things are quite a bit grayer. In the case of physical things, the "obviousness" test is a little easier to apply because everyone has some familiarity with tools and objects, and R&D can be fairly expensive for a lot of simple end products. It seems to me that the underlying theory of patents is fundamentally sound, but just has absolutely no applicability to software.
- esspem 17y agoWhy do you think software business model can't be applied to drug development? On of the biggest problem with drug research is that it's highly regulated by government, so it's too costly for a small startup. Remove this regulations and you'll get a software-like situation with thousands of startups and new drugs. e.g. read this: http://daniellefong.com/2010/02/11/how-law-shapes-the-business-landscape-and-a-patent-puzzle/ http://daniellefong.com/2010/02/11/how-law-shapes-the-busine...
- barmstrong 17y agoExactly what I was thinking....the main reason drug development cost all those millions (and I believe about 10 years on average) is the FDA. We should be careful not to let one mistake justify another.
- hugh3 17y agoWhile the current FDA system may be overkill, do you really want the market flooded with new drugs whose effects aren't well understood?
- cousin_it 17y agoThat depends on whether you prefer to die from taking an untested drug or die because the drug isn't invented yet. A severely ill person would probably prefer a chance of the former to the certainty of the latter. Also you have to account for the odds of both these events: which one do you think will happen more?
- ErrantX 17y agoThat's something of a straw man though. Because the vast majority of people taking drugs aren't dying. If new drugs created in the deregulated industry were only given to terminal cases as a last resort it might work; otherwise it is just endangering everyone else (taking drugs).
- cousin_it 17y agoNobody's endangering you. You're free to take only drugs approved by the newly private FDA Corp.
- ErrantX 17y agoAnd how do you objectively decide which ones are safe and which have been tested sufficiently to your requirements? As an individual deciding a drug is safe to use should not require you to read all the relevant research etc. - you need a safe, objective marker. i.e. law and regulation.
- esspem 17y agoYou will decide it because of mark "FDA approved" (or any other drug testing agency you trust) on the drug.
- ErrantX 17y agoWoah. I'm a big advocate of deregulation of many things but doing it to drugs seems a very dangerous idea. In the first place these are things that can seriously affect your health - it makes sense to demand these are tested before they can be sold to people. Secondly it would give more credence to the anti-drugs and pseudo-medicine movements. At the moment at least the govt. agencies can make a decision on if a drug is safe or not; with that out of the way it becomes even more of a PR war. :D (additionally I would argue that the bar for entry into drugs research is higher than it is into software development, I don't think you could evolve an environment as diverse and self sustaining as the software world)
- dantheman 17y agoYou seem to discount the amount of people that are dying due to the slow development cycle of drugs. If there was regulation there would be more experimentation, perhaps more people would die from the effects of new drugs -- but you could choose to only use drugs that have been stable and well studied while those who have nothing left to lose could use medicine directly off the chemists work bench.
- thaumaturgy 17y agoYou seem to discount the number of people that think homeopathics are an effective medicine.
- ErrantX 17y ago> perhaps more people would die from the effects of new drugs I'd argue this is almost certainly a given. But the problem is not those who die now - but those who are taken ill much later down the line. Ten years or whatever. > but you could choose to only use drugs that have been stable and well studied while those who have nothing left to lose could use medicine directly off the chemists work bench. I entirely agree with the sentiment there (it would be great to see the wider liberalisation and faster iteration of new drug trials for example). but (and I feel this is a big caveat) how do people decide which drug is stable and well studied. It is not necessarily sufficient to trust the pamphlet or advertising the company gives you. I don't know. Maybe it is cynicism but I suspect that if drug research were deregulated the standard of drugs produced would decline rapidly. And finally; I am not so sure drugs research would explode with innovation. We would get drugs to market faster, sure, but there is a standard of entry into drug research that still requires funding, education and resources.
- Locke1689 17y agoUhh no. The biggest problem with drug research is the ridiculously high amount of initial capital it takes to develop a drug. You can't just throw out buzzwords like "startups" and "software" like they're a panacea.
- esspem 17y agoI think you are wrong. There are a lot of small pharmaceuticals startups. http://www.newsobserver.com/2010/04/14/436028/drug-startup-arbor-is-sold.html http://www.newsobserver.com/2010/04/14/436028/drug-startup-a... http://www.facebook.com/group.php?gid=2355897150 http://www.facebook.com/group.php?gid=2355897150 http://industry.bnet.com/pharma/10006932/biotech-start-up-flexion-takes-the-stodgy-out-of-big-pharma-rd/ http://industry.bnet.com/pharma/10006932/biotech-start-up-fl...
- Locke1689 17y agoThere isn't actually a single company that has succeeded in bringing drug development under millions of dollars in that list. The closest is the last one, but that company hasn't actually produced any results yet.
- lutorm 17y agoIt's true that developing a pharmaceutical is an expensive process, but on the other hand the compounds used are often naturally occurring. In that sense, it seems to me that these are instances of "discovery" and not "invention", just like genome patents in general. I might be fine with restricting the right for others to sell pharmaceuticals based on the same compound for the same purpose, but certainly not to bar general research into what other effects it may have.
- pbhjpbhj 17y ago>I might be fine with restricting the right for others to sell pharmaceuticals based on the same compound for the same purpose, but certainly not to bar general research into what other effects it may have. There is a general exclusion of the monopoly right over that of the right to continue scientific research. One could find novel uses, but unless the patents have been poorly drafted it would be impossible to exploit them - you're simply finding more reasons for people to buy your competitors drug.
- anamax 17y ago> I might be fine with restricting the right for others to sell pharmaceuticals based on the same compound for the same purpose, but certainly not to bar general research into what other effects it may have. Umm, that's exactly what current patent law does. The recent denial of a "gene patent" affirmed that. The Viagra-for-ED patent doesn't keep me from patenting the use of the exact same compound as a floor wax.
- flipbrad 17y agoOuch, what a mishmash of the law goin' on here. ACLU v myriad wasn't about patentable second use of patented products, nor was it about obviousness over the state of the art (the natural world is not considered to be in the state of the art): it was about novelty - the natural DNA in your cells was, in the judge's view, still the same substance (even in cDNA form and artificially synthesised) as the chemical in Myriad's 'invention' (since for him, function was crucial not form - its form might be altered and origin be synthetic, its function is the same - to carry information - and that information is the same).